118 related articles for article (PubMed ID: 3012992)
21. Immunocytochemical detection of estrogen receptors in mammary Paget cells.
Tani EM; Skoog L
Acta Cytol; 1988; 32(6):825-8. PubMed ID: 2849272
[TBL] [Abstract][Full Text] [Related]
22. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
23. [Grading, staging, DNA content and prognosis of invasive ductal breast cancer].
Theissig F; Kunze KD; Haroske G; Meyer W; Dimmer V
Zentralbl Chir; 1990; 115(7):433-9. PubMed ID: 2164288
[TBL] [Abstract][Full Text] [Related]
24. Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.
Harvey J; de Klerk N; Berryman I; Sterrett G; Byrne M; Papadimitriou J
Breast Cancer Res Treat; 1987; 9(2):101-9. PubMed ID: 3304476
[TBL] [Abstract][Full Text] [Related]
25. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
[TBL] [Abstract][Full Text] [Related]
26. Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.
McCarty KS; Barton TK; Fetter BF; Woodard BH; Mossler JA; Reeves W; Daly J; Wilkinson WE; McCarty KS
Cancer; 1980 Dec; 46(12 Suppl):2851-8. PubMed ID: 6256054
[TBL] [Abstract][Full Text] [Related]
27. Nuclear DNA content in breast carcinomas with neuroendocrine differentiation.
Nesland JM; Pettersen EO; Fosså SD; Høie J; Johannessen JV
J Pathol; 1986 Nov; 150(3):181-5. PubMed ID: 3027292
[TBL] [Abstract][Full Text] [Related]
28. Microfluorometric grading of mammary tumors. A pilot study.
Patek E; Johannisson E; Krauer F; Riotton G
Anal Quant Cytol; 1980 Dec; 2(4):264-71. PubMed ID: 6258463
[TBL] [Abstract][Full Text] [Related]
29. Mammary carcinoma: comparison of DNA-content in the primary tumor and the corresponding axillary lymphnode metastases.
Erhardt K; Auer G
Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):29-34. PubMed ID: 3962678
[TBL] [Abstract][Full Text] [Related]
30. A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast.
Norris HJ; Bahr GF; Mikel UV
Anal Quant Cytol Histol; 1988 Feb; 10(1):1-9. PubMed ID: 2833287
[TBL] [Abstract][Full Text] [Related]
31. Retrospective DNa analysis of T3/T4 breast carcinoma using cytophotometry and flow cytometry. A comparative study with prognostic evaluation.
Roos G; Arnerlöv C; Emdin S
Anal Quant Cytol Histol; 1988 Jun; 10(3):189-94. PubMed ID: 3408544
[TBL] [Abstract][Full Text] [Related]
32. Feulgen DNA content and mitotic activity in proliferative breast disease. A comparison with ductal carcinoma in situ.
De Potter CR; Praet MM; Slavin RE; Verbeeck P; Roels HJ
Histopathology; 1987 Dec; 11(12):1307-19. PubMed ID: 2831133
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of image cytometry DNA parameters in tissue sections from breast and gastric cancers.
Haroske G; Kunze KD; Theissig F
Anal Cell Pathol; 1991 Jan; 3(1):11-24. PubMed ID: 1848088
[TBL] [Abstract][Full Text] [Related]
34. Nuclear DNA content and nuclear atypia. Relation to survival in patients with breast adenocarcinoma and serious ovarian tumors.
Erhardt K; Silfverswärd C; Auer G
Anticancer Res; 1989; 9(5):1325-30. PubMed ID: 2589823
[TBL] [Abstract][Full Text] [Related]
35. DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.
Baildam AD; Zaloudik J; Howell A; Barnes DM; Turnbull L; Swindell R; Moore M; Sellwood RA
Br J Cancer; 1987 May; 55(5):553-9. PubMed ID: 3038158
[TBL] [Abstract][Full Text] [Related]
36. Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer.
Aaltomaa S; Lipponen P; Papinaho S; Klemi P; Kosma VM; Marin S; Eskelinen M; Alhava E; Syrjänen K
Eur J Surg; 1992 Mar; 158(3):135-41. PubMed ID: 1356452
[TBL] [Abstract][Full Text] [Related]
37. The content of tumor DNA as an indicator of prognosis in patients with T1N0M0 and T2N0M0 carcinoma of the breast.
Ellis CN; Frey ES; Burnette JJ; Akin JM; Reading C; Gaskin TA; Blakemore WS
Surgery; 1989 Aug; 106(2):133-8. PubMed ID: 2763022
[TBL] [Abstract][Full Text] [Related]
38. RNA: DNA ratios in human tumors.
Hilf R
J Natl Cancer Inst; 1977 Oct; 59(4):1053-4. PubMed ID: 198554
[No Abstract] [Full Text] [Related]
39. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
40. Progression of mammary adenocarcinomas as reflected by nuclear DNA content.
Auer GU; Fallenius AG; Erhardt KY; Sundelin BS
Cytometry; 1984 Jul; 5(4):420-5. PubMed ID: 6468180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
